Form: SC 13G

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

September 11, 2023

Documents

 

 

Exhibit 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.01 par value per share, of Enzo Biochem, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.

 

Dated: September 11, 2023

 

1 Main Capital Management, LLC  
1 Main Capital Partners L.P.  
   
By: /s/ Yaron Naymark  
Name: Yaron Naymark  
Title: Authorized Signatory  
   
   
/s/ Yaron Naymark  
Yaron Naymark  

 

Page 10 of 10 Pages